– UK, Bracknell – Venture Life Group PLC (LON: VLG), a leader in developing, manufacturing, and commercializing products for the self-care market, today announced the appointment of Mark Adams to its Board as Non-Executive Director, with immediate effect.
“We are very pleased that Mark is joining our Board. His extensive expertise, experience and track record in building equity value in the public markets will undoubtedly deliver a valuable contribution to our future growth ambitions. Further, Mark’s significant experience in financial functions and governance within the public company environment will contribute significantly to our Board in these areas,” said CEO, Jerry Randall.
Mark Adams will also join the Audit Committee as its Chair
Concurrently, The company also announced that Peter Bream has stepped down from the Board.
About Mark Adams
With a nearly 30-year career working in senior finance roles across a range of sectors and companies, Mark Adams brings a wealth of relevant experience and expertise to VLG’s Board, including significant time as a Board director of several publicly listed companies. His most recent role was as Group Finance Director at Marlowe plc, a UK leader in business-critical services and software which assure safety and regulatory compliance. Before joining Marlowe plc, Mark Adams held senior financial and board-level roles at Stobart Group Limited, Pets at Home Group plc, easyJet plc, and a number of other businesses.
Mark is currently a Non-Executive Director and Audit Committee Chair at One Media iP Group plc and Development Media International plc.
Mark Adams said: “I am delighted to be joining the Venture Life Board at an exciting time in the development of the Company. I have been impressed by the ambitions of the team and I look forward to working with them and using my experience to support the further development of VLG.”
About Venture Life
Venture Life is an international consumer self-care company focused on developing, manufacturing, and commercializing products for the global self-care market. With operations in the UK, Italy, The Netherlands, and Sweden, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women’s intimate healthcare, the Lift, and Glucogel product ranges for hypoglycemia, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of aging. Its products are sold in over 90 countries worldwide.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands, these are supplied direct by the company to retailers, elsewhere they are supplied by the Group’s international distribution partners.
Through its two Development & Manufacturing operations in Italy and Sweden, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
For more information: https://www.venture-life.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
